Synchrony Financial Q2 2026 Earnings: Net Income Drops 8% to $885M, EPS $2.59; Full-Year EPS Guidance Lifted to $9.25–$9.50
SYF sits 21% above its 52-week low of $63.08.
Summary
Synchrony Financial's Q2 2026 earnings fell 8% to $885 million on higher credit costs, but the company lifted its full-year EPS outlook to $9.25–$9.50, reflecting strong purchase volume growth and improving credit quality.
Key Events · Earnings and Guidance · SYF
-
Q2 Earnings Miss Prior Year
Net earnings came in at $885 million, or $2.59 per diluted share, compared to $967 million, or $2.50 per diluted share, in Q2 2025. Revenue growth was offset by a higher provision for credit losses and increased operating expenses.
-
Full-Year EPS Guidance Raised
Management raised its 2026 EPS guidance to $9.25–$9.50, up from the prior outlook, driven by expected mid-single digit loan receivables growth and a net charge-off rate below 5.5%.
-
Capital Return Remains Aggressive
The company returned $950 million to shareholders in Q2, including $850 million in share repurchases and $100 million in dividends. The remaining buyback authorization stands at $5.7 billion.
-
Credit Quality Improves
The net charge-off rate fell to 5.43% from 5.70% a year ago. Delinquencies of 30+ days declined to 4.16% from 4.18%, and the allowance for credit losses decreased to 10.09% of loan receivables.
Analysis · SYF · Finance
Second-quarter 2026 net earnings at Synchrony Financial came in at $885 million, an 8% decline from the prior year, as a higher provision for credit losses and rising operating expenses outweighed record purchase volume and a wider net interest margin. Despite the earnings dip, the company raised its full-year EPS guidance to $9.25–$9.50, signaling confidence in accelerating loan growth and stable credit trends. Capital return remained aggressive, with $950 million deployed across buybacks and dividends, though the CET1 ratio edged down to 13.2%.
At the time of this filing, SYF was trading at $76.02 on NYSE in the Finance sector, with a market capitalization of approximately $24.7B. The 52-week trading range was $63.08 to $88.77. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.